Abstract

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse

Author(s): Williams LaVonn A

Issue: Nov/Dec 2011 - Volume 15, Number 6

Page(s): 526-527

Download in electronic PDF format for $75
  • PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Page 1
  • PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Page 2

Abstract

Related Keywords

  • drug disposal
  • prescription drug abuse
  • drug take-back events
  • U.S. Drug Enforcement Administration
  • DEA
  • controlled substances

Related Categories

  • LEGAL
  • PATIENT EDUCATION
  • ADVERSE DRUG EVENTS
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 400-403
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Author(s): Gilbert John A
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 446-450
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Author(s): Pore R David
Jan/Feb 2023
Pg. 22-23
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Author(s): Brunner Scott
Sep/Oct 2015
Pg. 389-390
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 92
PreScription: Discontinued Drugs and Drug Shortages
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 298-301
The Role of Compounding Pharmacists During Drug Shortages
Author(s): Ofei Kelvin
Sep/Oct 2014
Pg. 379-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Author(s): Blankenship Cynthia E
May/Jun 2014
Pg. 208
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Author(s): Miller David G
Jul/Aug 2012
Pg. 294-298
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Author(s): Allen Loyd V Jr, Williams LaVonn A
Jan/Feb 2014
Pg. 35-36
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Author(s): Miller David G
Mar/Apr 2010
Pg. 131-133
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs
Author(s): Burke John, Hill Jeff
Jul/Aug 2007
Pg. 350-351
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Sep/Oct 2015
Pg. 377-380
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake